Commerzbank Aktiengesellschaft’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,041
| Closed | -$202K | – | 390 |
|
|
2025
Q3 | $202K | Buy |
+2,041
| New | +$202K | ﹤0.01% | 350 |
|
|
2025
Q2 | – | Sell |
-2,041
| Closed | -$232K | – | 373 |
|
|
2025
Q1 | $232K | Hold |
2,041
| – | – | 0.01% | 318 |
|
|
2024
Q4 | $216K | Buy |
+2,041
| New | +$219K | 0.01% | 317 |
|
|
2020
Q2 | – | Sell |
-3,020
| Closed | -$296K | – | 428 |
|
|
2020
Q1 | $296K | Buy |
+3,020
| New | +$396K | 0.01% | 346 |
|
|
2019
Q2 | – | Sell |
-1,873
| Closed | -$232K | – | 1087 |
|
|
2019
Q1 | $232K | Sell |
1,873
-1,031
| -36% | -$117K | ﹤0.01% | 765 |
|
|
2018
Q4 | $292K | Buy |
2,904
+563
| +24% | +$63.3K | ﹤0.01% | 769 |
|
|
2018
Q3 | $299K | Sell |
2,341
-1,789
| -43% | -$213K | ﹤0.01% | 790 |
|
|
2018
Q2 | $447K | Sell |
4,130
-2,879
| -41% | -$313K | ﹤0.01% | 695 |
|
|
2018
Q1 | $742K | Buy |
7,009
+4,663
| +199% | +$542K | 0.01% | 602 |
|
|
2017
Q4 | $275K | Sell |
2,346
-1,113
| -32% | -$126K | ﹤0.01% | 777 |
|
|
2017
Q3 | $393K | Buy |
+3,459
| New | +$399K | 0.01% | 657 |
|
|
2017
Q2 | – | Sell |
-4,898
| Closed | -$581K | – | 905 |
|
|
2017
Q1 | $581K | Buy |
4,898
+686
| +16% | +$77.8K | 0.01% | 604 |
|
|
2016
Q4 | $422K | Buy |
4,212
+1,418
| +51% | +$152K | 0.01% | 669 |
|
|
2016
Q3 | $353K | Sell |
2,794
-4,313
| -61% | -$533K | 0.01% | 670 |
|
|
2016
Q2 | $831 | Buy |
7,107
+988
| +16% | +$112K | 0.01% | 518 |
|
|
2016
Q1 | $633K | Sell |
6,119
-4,961
| -45% | -$480K | 0.01% | 615 |
|
|
2015
Q4 | $1.1M | Buy |
11,080
+5,378
| +94% | +$526K | 0.01% | 625 |
|
|
2015
Q3 | $520K | Sell |
5,702
-13,338
| -70% | -$1.34M | ﹤0.01% | 759 |
|
|
2015
Q2 | $2.02M | Sell |
19,040
-2,196
| -10% | -$243K | 0.01% | 605 |
|
|
2015
Q1 | $2.42M | Sell |
21,236
-4,341
| -17% | -$495K | 0.01% | 556 |
|
|
2014
Q4 | $2.82M | Sell |
25,577
-29,694
| -54% | -$3.13M | 0.02% | 553 |
|
|
2014
Q3 | $5.4M | Buy |
55,271
+12,008
| +28% | +$1.18M | 0.02% | 466 |
|
|
2014
Q2 | $4.36M | Sell |
43,263
-3,332
| -7% | -$325K | 0.02% | 495 |
|
|
2014
Q1 | $4.28M | Buy |
46,595
+1,485
| +3% | +$137K | 0.02% | 501 |
|
|
2013
Q4 | $4.12M | Sell |
45,110
-13,248
| -23% | -$1.15M | 0.02% | 535 |
|
|
2013
Q3 | $4.65M | Sell |
58,358
-11,764
| -17% | -$926K | 0.02% | 486 |
|
|
2013
Q2 | $5.1M | Buy |
+70,122
| New | +$5.24M | 0.02% | 526 |
|
Other funds holding ZBH
Commerzbank Aktiengesellschaft's ZBH Position: Q4 2025 in Review
Commerzbank Aktiengesellschaft sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 2,041 shares — an estimated $202K sold.
Commerzbank Aktiengesellschaft first reported a position in ZBH in Q2 2013 and held it in 27 quarters. The position peaked at $5.4M in Q3 2014. 946 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.
- Commerzbank Aktiengesellschaft reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
- Commerzbank Aktiengesellschaft sold 2,041 Zimmer Biomet shares in Q4 2025, an estimated $202K.
- Commerzbank Aktiengesellschaft first reported a position in Zimmer Biomet in Q2 2013 and held it in 27 quarters.
- Commerzbank Aktiengesellschaft's Zimmer Biomet position peaked at $5.4M in Q3 2014.
- 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2025, filed 5 Feb 2026.